By Professor Michelle Haber

Conference Presentations

Lau L; Khuong-Quang D-A; Nagabushan S; Senapati A; Barahona P; Ajuyah P; Altekoester A-K; Wong M; Mayoh C; Mould E; Fuentes-Bolanos N; Zhukova N; Cowley M; Ekert P; Tyrrell V; Trahair T; Haber M; Marshall G; Ziegler D, 2021, 'Precision Medicine for High-Risk Paediatric Cancers - Molecular Tumour Board Recommendations and Treatment Responses (Zero Childhood Cancer Program)', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000708132100110&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shahbazi J; Scarlett CJ; Norris M; Liu B; Haber M; Tee AE; Carrier A; Biankin AV; London WB; Marshall GM; Lock R; Liu T, 2014, 'Abstract 5138: Histone deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1', http://dx.doi.org/10.1158/1538-7445.am2014-5138

Back to profile page